The distribution company informed its supplied customers on 04/16/2014 and asked for a stock check of the affected batch.

The marketing authorization holder has informed its wholesalers in a letter dated April 11, 2014, that the contract manufacturer for…

The marketing authorization holder informed its wholesalers in a letter dated April 10, 2014, that GlaxoSmithKline (GSK) had received a warning letter…

The marketing authorization holder informed its supplied customers in a letter dated March 21, 2014, that an internal review determined that the…

The marketing authorization holder informed its supplied customers in a letter dated March 20, 2014, that isolated blisters of Calmolan 0.18 mg (packs…

The marketing authorization holder informed its supplied customers in a letter dated 19.03.2014 that underfilling of the15 ml package size had been…

"Janssen-Cilag Pharma GmbH" informed its supplied customers in a letter dated March 13, 2014, that due to continuous assessment of the product…

Madaus Ges.m.b.H." has informed its supplied customers by letter dated 11.03.2014 that within the framework of ongoing stability tests, quality…

The distributor has informed its supplied customers in a letter dated March 5, 2014, that ten batches were identified during investigations that…

In a letter dated February 21, 2014, the distributor informed the customers it supplied that marginal manufacturing deviations had been identified,…